8-K 1 kl00889_8-k.txt FORM 8-K CURRENT REPORT SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 __________________________________ FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): August 24, 2005 __________ Elbit Medical Imaging Ltd. (Exact name of registrant as specified in its charter) Israel 000-28996 None (State or other jurisdiction of (Commission file (I.R.S. employer incorporation or organization) number) identification no.) 13 Mozes Street 67442 Tel Aviv, Israel (Zip code) (Address of principal executive offices) Registrant's telephone number, including area code: 011 (972-3) 608-6010 Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below): [ ] Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) [ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) [ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) [ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c) Item 8.01. Other Events ------------ EMI Medical Imaging Ltd. (the "Registrant") is filing this current report on Form 8-K in order to file a consent of one of its independent accountants to the incorporation by reference of the report of such accountants with respect to the Registrant's audited consolidated financial statements for the year ended December 31, 2004 (the "2004 Financial Statements") in the registration statement on Form S-8 (relating to the registration of shares to be used under the Elbit Medical Imaging Ltd. 2001 Incentive Plan to Employees and Officers, File Number 333-117509) filed by the Registrant prior to the date hereof. The 2004 Financial Statements were filed by the Registrant with the Securities and Exchange Commission as part of its Annual Report on Form 20-F for the fiscal year ended December 31, 2004. Item 9.01 Financial Statements and Exhibits --------------------------------- (c) Exhibits Exhibit No. Description ----------- ----------- 23.1 Consent of Mazars Paardekooper Hoffman SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, EMI Medical Imaging Ltd. has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized. Date: August 24, 2005 ELBIT MEDICAL IMAGING LTD. By: /s/Shimon Yitzhaki ---------------------- Name: Shimon Yitzhaki Title: President Exhibit Index Exhibit No. Description ----------- ----------- 23.1 Consent of Mazars Paardekooper Hoffman